1 terminated, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Chronic Graft-versus-host Disease: new trials by email Literature Review of Chronic Graft-versus-host Disease trials Research Report on Chronic Graft-versus-host Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease Itacitinib, Placebo, Methylprednisolone - Chronic Graft-versus-host Disease | Phase 2 / Phase 3 | Terminated | Incyte Corporation | 155 | 2019-01-17 | 2025-10-20 |
| Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells Mesenchymal Stromal Cells - Chronic Graft-Versus-Host Disease | Phase 3 | Unknown | Guangdong Provincial People's Hospital | 130 | 2014-10-01 | 2014-11-14 |
Bronchiolitis Obliterans Syndrome (2) · Graft vs Host Disease (1)
Bronchial Diseases (2) · Bronchiolitis (2) · Bronchiolitis Obliterans (2) · Bronchitis (2) · Immune System Diseases (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Organizing Pneumonia (2) · Respiratory Tract Diseases (2) · Graft vs Host Disease (1)
INCB039110 (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Prednisone (1) · itacitinib (1)
Guangdong Provincial People's Hospital (1) · Incyte Corporation (1)
Austria (1) · Belgium (1) · Canada (1) · China (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Poland (1) · Spain (1) · Sweden (1) · Switzerland (1)
Rodica Morariu-Zamfir, MD (1) · Xin Du, Prof. (1)
2018 (1)